Sep 16, 2026 09:00AM
Sep 3, 2026 09:00AM
May 27, 2026 08:04AM
May 27, 2026 08:04AM
Feb 5, 2026 08:04AM
Feb 5, 2026 08:04AM
Dec 11, 2025 08:05AM TransCode launches phase 2a trial for cancer drug TTX-MC138
Dec 11, 2025 08:05AM
May 28, 2025 08:01AM
May 28, 2025 08:00AM
Jun 10, 2024 07:00AM
Jun 10, 2024 06:03AM
Apr 15, 2024 09:01AM
Apr 15, 2024 09:00AM TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
Apr 3, 2024 09:10AM
Apr 3, 2024 09:10AM
Jan 4, 2024 08:06AM
Jan 4, 2024 08:05AM
Nov 14, 2023 04:30PM
Aug 14, 2023 04:45PM
Jun 22, 2023 07:01AM TransCode Therapeutics (RNAZ) Announces Publication of New Data Supporting the Use of TTX-MC138
Jun 22, 2023 07:00AM
Apr 27, 2023 07:00AM
Apr 27, 2023 07:00AM
Apr 27, 2023 07:00AM
Apr 6, 2023 07:00AM
Apr 6, 2023 07:00AM
Mar 31, 2023 04:01PM TransCode Therapeutics Reports 2022 Results; Provides Business Update
Mar 31, 2023 04:01PM
Feb 28, 2023 07:16AM
Feb 28, 2023 07:00AM
Feb 28, 2023 07:00AM
Jan 31, 2023 04:05PM
Jan 31, 2023 04:05PM
Dec 29, 2022 08:00AM TransCode Therapeutics (RNAZ) Announces FDA Authorization to Proceed with First-In-Human Clinical Trial
Dec 29, 2022 08:00AM
Dec 29, 2022 08:00AM
Nov 30, 2022 07:01AM
Nov 30, 2022 07:00AM
Nov 30, 2022 07:00AM
Nov 14, 2022 04:15PM
Nov 14, 2022 04:15PM TransCode Therapeutics Reports Third Quarter 2022 Results; Provides Business Update
Aug 15, 2022 04:15PM
Aug 15, 2022 04:15PM
Jun 14, 2022 11:49AM
May 16, 2022 08:30AM
May 16, 2022 08:30AM
Mar 31, 2022 04:30PM
Mar 31, 2022 04:30PM TransCode Therapeutics Reports 2021 Results; Provides Business Update
Feb 10, 2022 09:45AM

331,296 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All